Search

Your search keyword '"McCutchan Ja"' showing total 70 results

Search Constraints

Start Over You searched for: Author "McCutchan Ja" Remove constraint Author: "McCutchan Ja" Language undetermined Remove constraint Language: undetermined
70 results on '"McCutchan Ja"'

Search Results

1. Asymptomatic Malaria Co-infection of HIV-Infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood, and Biomarkers of Systemic Inflammation

2. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy

Catalog

Books, media, physical & digital resources

3. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

4. White matter damage, neuroinflammation, and neuronal integrity in HAND

5. Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria

6. Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study

7. A-03 Ethnic/Racial Differences in Longitudinal Neurocognitive Change among People Living with HIV

8. Neurocognitive impairment in HIV-infected individuals with previous syphilis

9. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era

10. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment

11. Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

12. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

13. Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

14. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

15. Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder

16. Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy

17. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

18. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

19. Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans

20. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

21. Neurocognitive Impairment Is an Independent Risk Factor for Death in HIV Infection

22. Azithromycin in the prophylaxis of opportunistic infections in AIDS

23. Stress and Depressive Symptoms Prospectively Predict Immune Change among HIV-Seropositive Men

24. Clinical Impact of Cytomegalovirus Infections of the Nervous System in Patients with AIDS

25. Cytomegalovirus Infections of the Nervous System in Patients with AIDS

26. Validity of the Quality of Well-Being Scale for Persons With Human Immunodeficiency Virus Infection

27. Prevalence and risk factors for HIV CSF Viral Escape: Results from the CHARTER and HNRP cohorts

28. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment

29. Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS

30. Neuroleptic Treatment of HIV-Associated Psychosis

31. Identification of Psychobiological Stressors Among HIV-Positive Women

32. Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages

33. A factor analysis of the Klein sexual orientation Grid in two disparate samples

34. Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment

35. Sensory Testing in Human Immunodeficiency Virus Type 1-Infected Men

36. Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis

37. Impact of Pneumocystis carinii and Cytomegalovirus on the Course and Outcome of Atypical Pneumonia in Advanced Human Immunodeficiency Virus Disease

38. Indinavir Population Pharmacokinetics in Plasma and Cerebrospinal Fluid

39. T-cell-induced expression of human immunodeficiency virus in macrophages

40. Localization of Human Cytomegalovirus in Peripheral Blood Leukocytes by In Situ Hybridization

41. Low CSF leptin levels are associated with worse learning and memory performance in HIV-infected men

42. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

43. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group

44. Neurocognitive impairment in human immunodeficiency virus infection is correlated with sexually transmitted disease history

45. Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center

46. Disseminated Mycobacterium avium complex: correlation between blood and tissue burden

47. Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection

48. Is gender dysphoria dysphoric? Elevated depression and anxiety in gender dysphoric and nondysphoric homosexual and bisexual men in an HIV sample. HNRC Group

49. A Common Polymorphism in the COMT Gene Confers an Increased Risk of Neuropathic Pain in HIV Sensory Neuropathy (S37.006)

50. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center